Managing breathlessness: A palliative care approach

Postgraduate Medical Journal

Volumn 92, Issue 1089, 2016, Pages 393-400

  Chin, Chloe ^a   Booth, Sara ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; DIAMORPHINE; HALOPERIDOL; LEVOMEPROMAZINE; MIDAZOLAM; MORPHINE; NARCOTIC ANALGESIC AGENT;

CHRONIC OBSTRUCTIVE LUNG DISEASE; COGNITIVE THERAPY; COST BENEFIT ANALYSIS; DYSPNEA; ENERGY CONSERVATION; FUNCTIONAL NEUROIMAGING; HEALTH CARE SYSTEM; HUMAN; INTERVENTION STUDY; MEDICAL RESEARCH; MORTALITY; MUSCLE EXCITATION; NAUSEA; OUTCOME ASSESSMENT; PALLIATIVE THERAPY; PRACTICE GUIDELINE; PSYCHOLOGIC ASSESSMENT; PULMONARY REHABILITATION; REVIEW; CLINICAL TRIAL (TOPIC); ORGANIZATION AND MANAGEMENT; PATIENT CARE; PATIENT COMFORT; PROCEDURES; RESPIRATORY CARE;

CLINICAL TRIALS AS TOPIC; DYSPNEA; HUMANS; PALLIATIVE CARE; PATIENT CARE MANAGEMENT; PATIENT COMFORT; RESPIRATORY THERAPY;

EID: 84963959642     PISSN: 00325473     EISSN: 14690756     Source Type: Journal    
DOI: 10.1136/postgradmedj-2015-133578     Document Type: Review

References (57)

1. Parshall MB, Schwartzstein RM, Adams L, et al. An official American thoracic society statement: Update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med 2012;185:435–52.
2. Booth S, Chin C, Spathis A. The brain and breathlessness: Understanding and disseminating a palliative care approach. Palliat Med 2015;29:396–8.
3. Epidemiology of Breathlessness—literature review by IMPRESS Breathlessness Working Party and London School of Economics and Political Science Department of Management supported by the Health Foundation. http://www.impressresp.com/index.php?option=com_docman&Itemid=82
4. Grnøseth R, Vollmer WM, Hardie JA, et al. Predictors of dyspnoea prevalence: results from the BOLD study. Eur Respir J 2014;43:1610–20.
5. Hubbard R. The burden of lung disease, 2nd Edition. A Statistics Report from the British Thoracic Society. Thorax 2006;61:557–8.
6. Currow DC, Smith J, Davidson PM, et al. Do the trajectories of dyspnea differ in prevalence and intensity by diagnosis at the end of life? A consecutive cohort study. J Pain Symptom Manage 2010;39:680–90.
7. Currow DC, Plummer JL, Crockett A, et al. A community population survey of prevalence and severity of dyspnea in adults. J Pain Symptom Manage 2009;38:533–45.
8. Edmonds P, Karlsen S, Khan S, et al. A comparison of the palliative care needs of patients dying from chronic respiratory diseases and lung cancer. Palliat Med 2001;15:287–95.
9. Gardener C, Farquhar M, Butcher HH, et al. Depression and anxiety: impact on service use in patients with advanced chronic obstructive pulmonary disease. BMJ Support Palliat Care 2015;5:112.
10. Nishimura K, Izumi T, Tsukino M, et al. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 2002;121:1434–40.
11. Mentz RJ, Mi X, Sharma PP, et al. Relation of dyspnea severity on admission for acute heart failure with outcomes and costs. Am J Cardiol 2015;115:75–81.
12. Frostad A, Søyseth V, Andersen A, et al. Respiratory symptoms as predictors of all-cause mortality in an urban community: a 30-year follow-up. J Intern Med 2006;259:520–9.
13. Steer J, Norman EM, Afolabi OA, et al. Dyspnoea severity and pneumonia as predictors of in-hospital mortality and early readmission in acute exacerbations of COPD. Thorax 2012;67:117–21.
14. Banzett RB, O’Donnell CR. Should we measure dyspnoea in everyone? Eur Respir J 2014;43:1547–50.
15. Booth S, Burkin J, Moffat C, et al. Managing breathlessness in clinical practice. Springer, 2014.
16. Pattinson KTS, Johnson MJ. Neuroimaging of central breathlessness mechanisms. Curr Opin Support Palliat Care 2014;8:225–33.
17. von Leupoldt A, Sommer T, Kegat S, et al. The unpleasantness of perceived dyspnea is processed in the anterior insula and amygdala. Am J Respir Crit Care Med 2008;177:1026–32.
18. Weingärtner V, Scheve C, Gerdes V, et al. Characteristics of episodic breathlessness as reported by patients with advanced chronic obstructive pulmonary disease and lung cancer: results of a descriptive cohort study. Palliat Med 2015;29: 420–8.
19. Hayes AW, Philip J, Spruyt OW. Patient reporting and doctor recognition of dyspnoea in a comprehensive cancer centre. Intern Med J 2006;36:381–4.
20. De Peuter S, Van Diest I, Lemaigre V, et al. Dyspnea: the role of psychological processes. Clin Psychol Rev 2004;24:557–81.
21. Meek PM, Banzett R, Parshall MB, et al. Reliability and validity of the multidimensional dyspnea profile. Chest 2012;141:1546–53.
22. Banzett RB, O’Donnell CR, Guilfoyle TE, et al. Multidimensional Dyspnea Profile: an instrument for clinical and laboratory research. Eur Respir J 2015;45:1681–91.
23. Yorke J, Moosavi SH, Shuldham C, et al. Quantification of dyspnoea using descriptors: Development and initial testing of the Dyspnoea-12. Thorax 2010;65:21–6.
24. Bestall JC, Paul EA, Garrod R, et al. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999;54:581–6.
25. Farquhar MC, Prevost AT, McCrone P, et al. Is a specialist breathlessness service more effective and cost-effective for patients with advanced cancer and their carers than standard care? Findings of a mixed-method randomised controlled trial. BMC Med 2014;12:194.
26. Higginson IJ, Bausewein C, Reilly CC, et al. An integrated palliative and respiratory care service for patients with advanced disease and refractory breathlessness: a randomised controlled trial. Lancet Respir Med 2014;2:979–87.
27. Bausewein C, Booth S, Gysels M, et al. Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases. Cochrane Dat Syst Rev 2008;(2):CD005623.
28. Schwartzstein RM, Lahive K, Pope A, et al. Cold facial stimulation reduces breathlessness induced in normal subjects. Am Rev Respir Dis 1987;136:58–61.
29. Galbraith S, Fagan P, Perkins P, et al. Does the use of a handheld fan improve chronic dyspnea? A randomized, controlled, crossover trial. J Pain Symptom Manage 2010;39:831–8.
30. Howard C, Dupont S. ‘The COPD breathlessness manual’: a randomised controlled trial to test a cognitive-behavioural manual versus information booklets on health service use, mood and health status, in patients with chronic obstructive pulmonary disease. NPJ Prim Care Respir Med 2014;24:14076.
31. Zwerink M, Brusse-Keizer M, van der Valk PD, et al. Self management for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2014;3: CD002990.
32. McCarthy B, Casey D, Devane D, et al. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2015;2:CD003793.
33. Bott J, Blumenthal S, Buxton M, et al. Guidelines for the physiotherapy management of the adult, medical, spontaneously breathing patient. Thorax 2009;64(Suppl 1):i1–52.
34. Holland AE, Hill CJ, Jones AY, et al. Breathing exercises for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2012;10:CD008250.
35. Booth S, Moffat C, Burkin J. The Cambridge Breathlessness Intervention Service Treatment Manual: Building a Breathlessness Service. Cambridge: Cambridge University Hospitals NHS Foundation Trust, 2011.
36. Abernethy AP, Currow DC, Frith P, et al. Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea. BMJ 2003;327:523–8.
37. Jennings A-L, Davies AN, Higgins JPT, et al. A systematic review of the use of opioids in the management of dyspnoea. Thorax 2002;57:939–44.
38. Ekström M, Nilsson F, Abernethy AA, et al. Effects of opioids on breathlessness and exercise capacity in chronic obstructive pulmonary disease. A systematic review. Ann Am Thorac Soc 2015;12:1079–92.
39. Bruera E, Macmillan K, Pither J, et al. Effects of morphine on the dyspnea of terminal cancer patients. J Pain Symptom Manage 1990;5:341–4.
40. Ekström MP, Bornefalk-Hermansson A, Abernethy AP, et al. Safety of benzodiazepines and opioids in very severe respiratory disease: national prospective study. BMJ 2014;348:g445.
41. Currow DC, McDonald C, Oaten S, et al. Once-daily opioids for chronic dyspnea: a dose increment and pharmacovigilance study. J Pain Symptom Manage 2011;42:388–99.
42. Simon ST, Higginson IJ, Booth S, et al. Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults (Review). Cochrane Database Syst Rev 2010;(1):CD007354.
43. [No authors listed]. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Report of the Medical Research Council Working Party. Lancet 1981;1:6816.
44. Uronis HE, Currow DC, McCrory DC, et al. Oxygen for relief of dyspnoea in mildlyor non-hypoxaemic patients with cancer: a systematic review and meta-analysis. Br J Cancer 2008;98:294–9.
45. Abernethy AP, McDonald CF, Frith PA, et al. Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnea: a double-blind, randomised controlled trial. Lancet 2010;376:784–93.
46. Uronis H, McCrory DC, Samsa G, et al. Symptomatic oxygen for non-hypoxaemic chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2011;(6): CD006429.
47. Campbell ML, Yarandi H, Dove-Medows E. Oxygen is nonbeneficial for most patients who are near death. J Pain Symptom Manage 2013;45:517–23.
48. Hardinge M, Annandale J, Bourne S, et al. British Thoracic Society guidelines for home oxygen use in adults. Thorax 2015;70(Suppl 1):i1–43.
49. National Collaborating Centre for Cancer (UK). The diagnosis and treatment of lung cancer. 2011. http://www.ncbi.nlm.nih.gov/books/NBK99023/
50. NHS Scotland. Scottish Palliative Care Guidelines. Breathlessness. Jun 2015. http://www.palliativecareguidelines.scot.nhs.uk
51. NICE CKS. Palliative care—dyspnoea. 2015. http://cks.nice.org.uk/ palliative-care-dyspnoea
52. IMPRESS. Breathlessness IMPRESS tips for clinicians. 2014. http://www.impressresp. com
53. Jennings AL, Davies AN, Higgins JPT, et al. WITHDRAWN: Opioids for the palliation of breathlessness in advanced disease and terminal illness. Cochrane Database Syst Rev 2012;7:CD002066.
54. Shohrati M, Ghanei M, Harandi AA, et al. Effect of nebulized morphine on dyspnea of mustard gas-exposed patients: A double-blind randomized clinical trial study. Pulm Med 2012;2012:610921.
55. Chin C, Butcher HH, Spathis A, et al. What’s trending in breathlessness research? Proceedings from the 8th Annual Meeting of the Breathlessness Research Interest Group. Prog Palliat Care 2015;23:326–30.
56. Faull OK, Jenkinson M, Clare S, et al. Functional subdivision of the human periaqueductal grey in respiratory control using 7 tesla fMRI. Neuroimage 2015;113:356–64.
57. Molassiotis A, Lowe M, Blackhall F, et al. A qualitative exploration of a respiratory distress symptom cluster in lung cancer: Cough, breathlessness and fatigue. Lung Cancer 2011;71:94–102.